QA: Tonix Pharmaceuticals Holding Corp in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001430306_2024_Tonix_Pharmaceuticals_Holding_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp

  xvar xval
0 AssetsCurrent 47,768,000
1 IntangibleAssetsNetIncludingGoodwill 10,708,000
2 PropertyPlantAndEquipmentNet 94,028,000
3 remainder_Assets 1,953,000
4 LiabilitiesCurrent 18,884,000
5 LiabilitiesNoncurrent 7,193,000
6 remainder_Liabilities 22,855,000
7 CostOfGoodsAndServicesSold 4,741,000
8 SellingGeneralAndAdministrativeExpense 44,284,940
9 ResearchAndDevelopmentExpense 92,340,826
10 remainder_Expenses 0
11 remainder_Revenues 7,768,000
12 remainder_NetIncome 1,734,370
13 remainder_ComprehensiveNetIncome -67,059
  yvar yval
0 Assets 154,457,000
1 Liabilities 48,932,000
2 Expenses 141,366,766
3 Revenues 7,768,000
4 StockholdersEquity 105,525,000
5 NetIncome -131,864,396
6 ComprehensiveNetIncome -131,897,926
7 BaseVar 177,162,598
8 EconomicCapitalRatiobeforeLimitedLiability 0.965
9 EconomicCapitalRatio 2.27

Edgar->Model Mapping

Feature Distribution

Change over Time